AUTHOR=Yi Hua-Wei , Wang Xian-Mo , Tan Xin , Ding Cai-Zhi , Zhang Chang-Li , Wu Jia-Hao , Li Qi , Xin Chen-Qi , Fan Wen TITLE=Simultaneous detection of human norovirus GI, GII and SARS-CoV-2 by a quantitative one-step triplex RT-qPCR JOURNAL=Frontiers in Microbiology VOLUME=14 YEAR=2024 URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1269275 DOI=10.3389/fmicb.2023.1269275 ISSN=1664-302X ABSTRACT=Background

There are many similarities in the clinical manifestations of human norovirus and SARS-CoV-2 infections, and nucleic acid detection is the gold standard for diagnosing both diseases. In order to expedite the identification of norovirus and SARS-CoV-2, a quantitative one-step triplex reverse transcription PCR (RT-qPCR) method was designed in this paper.

Methods

A one-step triplex RT-qPCR assay was developed for simultaneous detection and differentiation of human norovirus GI (NoV-GI), GII (NoV-GII) and SARS-CoV-2 from fecal specimens.

Results

The triplex RT-qPCR assay had high detection reproducibility (CVā€‰<ā€‰1%) and sensitivity. The lower limits of detection (LLOD95) of the triplex RT-qPCR assay for each target site were 128.5ā€“172.8 copies/mL, and LLOD95 of the singleplex RT-qPCR assay were 110.3ā€“142.0 copies/mL. Meanwhile, among the detection of clinical oropharyngeal swabs and fecal specimens, the results of the singleplex and triplex RT-qPCR assay showed high agreement.

Conclusion

The triplex RT-qPCR assay for simultaneous detection of NoV-GI, NoV-GII and SARS-CoV-2 from fecal specimens has high clinical application value.